AMZN
Amazon.com, Inc.
AMZN has the edge over UAA overall, supported by stronger valuation and lower modeled downside.
UAA
Under Armour, Inc.
UAA's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
UAA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
UAA's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
UAA PE Valuation
UAA has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 44x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over UAA on the outlook, with more favorable revenue expectations.
UAA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UAA to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over UAA on earnings quality, reporting a profit while its opponent remains loss making.
UAA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.11 | — |
| Q3 2026 | -$1.11 | -$0.90 |
| Q2 2026 | -$1.15 | -623% |
| Q1 2026 | -$1.16 | -$0.69 |
| Q4 2025 | -$1.22 | -$0.93 |
| Q3 2025 | -$0.21 | -$0.18 |
| Q2 2025 | $0.22 | +$0.40 |
| Q1 2025 | -$0.47 | -187% |
| Q4 2024 | -$0.29 | -133% |
UAA is still losing money, but less than at its worst: $1.11 per share over the past year, against $1.64 at its worst in late 2020.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over UAA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over UAA on profitability, with a higher operating margin.
UAA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | -6.9% |
| Q2 2026 | $1.1B | -3.2% |
| Q1 2026 | $1.2B | -0.8% |
| Q4 2025 | $1.3B | -5.2% |
| Q3 2025 | $1.3B | -4.7% |
| Q2 2025 | $1.1B | -4.2% |
| Q1 2025 | $1.2B | -11% |
| Q4 2024 | $1.4B | -5.7% |
UAA's revenue has slid since its 2022 peak: $1.2B last quarter, down 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.2% | -0.1 points |
| Q2 2026 | 4.3% | +4 points |
| Q1 2026 | -2.9% | +3.2 points |
| Q4 2025 | -11% | -12 points |
| Q3 2025 | 1.3% | -11 points |
| Q2 2025 | 0.3% | +26 points |
| Q1 2025 | -6.1% | -5.8 points |
| Q4 2024 | 1% | -3.7 points |
UAA's operating margin was 1.2% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
UAA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$101.7M | -$11.4M |
| Q2 2026 | $94.5M | +601% |
| Q1 2026 | -$347.3M | -$116.3M |
| Q4 2025 | $261.9M | -0.4% |
| Q3 2025 | -$90.3M | +$276.9M |
| Q2 2025 | $13.5M | -87% |
| Q1 2025 | -$231M | -$74.3M |
| Q4 2024 | $262.9M | -31% |
UAA has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
UAA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -2.3M shares |
| 1 year | +0.3% | +1.3M shares |
| 3 years | -5.3% | -24M shares |
| 5 years | -9.2% | -43.4M shares |
| Available history | -5.4% | -24.6M shares |
UAA has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $25M |
| Q2 2025 | — |
| Q1 2025 | $25M |
| Q4 2024 | $25M |
| Q3 2024 | — |
| Q2 2024 | $40M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
UAA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 9.0x | High |
| Q2 2025 | 0.3x | Very low |
| Q4 2024 | -8.2x | Net Cash |
| Q3 2024 | 0.8x | Very low |
| Q2 2024 | -5.6x | Net Cash |
| Q1 2024 | -0.5x | Net Cash |
| Q4 2023 | -0.9x | Net Cash |
| Q3 2023 | 0.1x | Very low |
UAA's net debt is about 9.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
UAA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 33.4 | Neutral |
UAA's weekly RSI is 44 (neutral) and its Stochastic is 33 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
UAA PE vs Consumer Cyclical Sector
| Metric | UAA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
UAA has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over UAA on trend strength, trading above more of its moving averages.
UAA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.83 | 1.4% above |
| 20 week MA | $5.52 | 11% below |
| 50 week MA | $5.80 | 16% below |
| 100 week MA | $6.02 | 19% below |
| 200 week MA | $7.04 | 30% below |
UAA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 30% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over UAA on returns for 2026, with the stronger performance.
UAA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.5 | $17.4 | -19% |
| 2021 | $17.4 | $20.6 | +18% |
| 2022 | $20.6 | $9.77 | -53% |
| 2023 | $9.77 | $8.79 | -10% |
| 2024 | $8.79 | $8.38 | -4.7% |
| 2025 | $8.38 | $4.65 | -45% |
| 2026 YTD | $4.65 | $4.90 | +5.4% |
UAA has finished four years in a row lower, and it's up 5.4% so far in 2026.